Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2025
Total Assets: $86.71B
Liabilities Breakdown FY2025
Total Liabilities: $34.58B
Asset Breakdown
Total Assets: $86.71B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $8.52B | 9.8% |
| Accounts Receivable | $7.93B | 9.1% |
| Inventory | $6.49B | 7.5% |
| Property, Plant & Equipment | $11.82B | 13.6% |
| Goodwill | $24.04B | 27.7% |
| Intangible Assets | $5.53B | 6.4% |
| Other Assets | $22.40B | 25.8% |
Liabilities Breakdown
Total Liabilities: $34.58B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.24B | 12.3% |
| Long-Term Debt | $9.90B | 28.6% |
| Other Liabilities | $20.45B | 59.1% |